Doctors sue FDA for campaigning against use of ivermectin to treat COVID-19
Quote from: https://www.naturalnews.com/2022-06-10-doctors-sue-fda-for-campaigning-against-ivermectin.html#
Physicians filed a lawsuit against the Food and Drug Administration (FDA) for acting outside of its authority by directing the public not to use ivermectin.
The legal action filed on June 2 by Drs. Robert L. Apter, Mary Talley Bowden and Paul E. Marik indicated that the FDA launched a “crusade” against ivermectin as a treatment for the Wuhan coronavirus (COVID-19), “unlawfully interfered” with the doctors’ ability to practice medicine – even though the drug is fully approved by the agency for human use.
The suit filed in the District Court, Southern District of Texas, Galveston Division also included the Department of Health and Human Services (HHS), HHS Secretary Xavier Becerra and FDA Commissioner Robert Califf.
“The FDA generally cannot ban particular uses of human drugs once they are otherwise approved and admitted to the market, even if such use differs from the labeling – commonly referred to as ‘off-label’ use,” the complaint stated.
The lawsuit also added that the FDA cannot advise whether a patient should take an approved drug for a particular purpose as decisions like these are within the scope of the doctor-patient relationship.
The doctors specifically mentioned the FDA publication “Why You Should Not Use Ivermectin to Treat or Prevent COVID-19” and tweets from the FDA official Twitter account – including one implying that ivermectin is intended only for animals.
“This lawsuit, brought by three eminently qualified physicians, is a welcome development,” said Mary Holland, Children’s Health Defense president and general counsel.
She told the Defender that the doctors rightfully assert that the FDA, assisted by corporate media, has unlawfully interfered with the doctor-patient relationship and the appropriate treatment for individual patients. “Regulating the doctor-patient relationship is an area of the well-established state law – not federal law,” she added.
Plaintiffs are respected practitioners with high success rates in treating COVID patients
The plaintiffs are well-respected in their field and hold records of high success rates in treating COVID-19 patients with ivermectin.
...
The legal action filed on June 2 by Drs. Robert L. Apter, Mary Talley Bowden and Paul E. Marik indicated that the FDA launched a “crusade” against ivermectin as a treatment for the Wuhan coronavirus (COVID-19), “unlawfully interfered” with the doctors’ ability to practice medicine – even though the drug is fully approved by the agency for human use.
The suit filed in the District Court, Southern District of Texas, Galveston Division also included the Department of Health and Human Services (HHS), HHS Secretary Xavier Becerra and FDA Commissioner Robert Califf.
“The FDA generally cannot ban particular uses of human drugs once they are otherwise approved and admitted to the market, even if such use differs from the labeling – commonly referred to as ‘off-label’ use,” the complaint stated.
The lawsuit also added that the FDA cannot advise whether a patient should take an approved drug for a particular purpose as decisions like these are within the scope of the doctor-patient relationship.
The doctors specifically mentioned the FDA publication “Why You Should Not Use Ivermectin to Treat or Prevent COVID-19” and tweets from the FDA official Twitter account – including one implying that ivermectin is intended only for animals.
“This lawsuit, brought by three eminently qualified physicians, is a welcome development,” said Mary Holland, Children’s Health Defense president and general counsel.
She told the Defender that the doctors rightfully assert that the FDA, assisted by corporate media, has unlawfully interfered with the doctor-patient relationship and the appropriate treatment for individual patients. “Regulating the doctor-patient relationship is an area of the well-established state law – not federal law,” she added.
Plaintiffs are respected practitioners with high success rates in treating COVID patients
The plaintiffs are well-respected in their field and hold records of high success rates in treating COVID-19 patients with ivermectin.
...
